EBITDA was up 8.9% to ₹2,298.2 crore in the third quarter of this fiscal over ₹2,111 crore in Q3 FY24. Shares of Dr Reddy’s Laboratories Ltd ended at ₹1,289.35, down by ₹6.95, or 0.54%, on the BSE.

EBITDA was up 8.9% to ₹2,298.2 crore in the third quarter of this fiscal over ₹2,111 crore in Q3 FY24. Shares of Dr Reddy’s Laboratories Ltd ended at ₹1,289.35, down by ₹6.95, or 0.54%, on the BSE.
+91 888 718 7394